KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

ClearPoint Neuro (CLPT) Return on Sales (2018 - 2025)

Historic Return on Sales for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to 0.66%.

  • ClearPoint Neuro's Return on Sales fell 500.0% to 0.66% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.68%, marking a year-over-year decrease of 800.0%. This contributed to the annual value of 0.63% for FY2024, which is 3100.0% up from last year.
  • Per ClearPoint Neuro's latest filing, its Return on Sales stood at 0.66% for Q3 2025, which was down 500.0% from 0.63% recorded in Q2 2025.
  • In the past 5 years, ClearPoint Neuro's Return on Sales ranged from a high of 0.54% in Q1 2024 and a low of 1.2% during Q2 2023
  • Moreover, its 5-year median value for Return on Sales was 0.74% (2022), whereas its average is 0.78%.
  • Its Return on Sales has fluctuated over the past 5 years, first tumbled by -4100bps in 2021, then surged by 6400bps in 2024.
  • ClearPoint Neuro's Return on Sales (Quarter) stood at 0.93% in 2021, then increased by 7bps to 0.86% in 2022, then rose by 20bps to 0.69% in 2023, then decreased by -5bps to 0.73% in 2024, then rose by 9bps to 0.66% in 2025.
  • Its Return on Sales was 0.66% in Q3 2025, compared to 0.63% in Q2 2025 and 0.71% in Q1 2025.